13F

Stock

Relmada Therapeutics, Inc.

RLMD · held by 3 managers

Reported value

$22.7K

Holders

3

+0 new · −0 exited

Holders’ est. mark

$1

Price effect on 1 books still in the name

Largest holder

$20.1K

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC10K$20.1K$1Added$20.1K
MORGAN STANLEY1.04K$2.09KHeld
BANK OF AMERICA CORP /DE/263$528Held

Positions as of Q3 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.